Aridis Pharmaceuticals, Inc.

Home » Aridis Pharmaceuticals, Inc.

IPO

Aridis Pharmaceuticals, Inc.

We are a late-stage biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

Symbol

ARDS

Price Range
$13.00 - $15.00

Final Shares
2,000,000

Anticipated Date
TBD

Underwriters
Cantor, Maxim Group LLC, Northland Capital Markets

To view the prospectus for Aridis Pharmaceuticals, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253